Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Pharma Stories, Blogs, Interviews & Press Releases

Importing Medicines into the United States and Canada: A Country-by-Country Guide (2026)
Importing Medicines into the United States and Canada: A Country-by-Country Guide (2026)

Last updated: 8 October 2026. Part of our region-by-region import guide series. Covers the United States and Canada. In...

Read Full Story
Importing Medicines into Europe and Turkey: A Country-by-Country Guide (2026)
Importing Medicines into Europe and Turkey: A Country-by-Country Guide (2026)

Last updated: 8 October 2026. Part of our region-by-region import guide series. Covers the European Union and EEA (as on...

Read Full Story
Importing Medicines into Japan, South Korea, Australia and New Zealand: A Country-by-Country Guide (2026)
Importing Medicines into Japan, South Korea, Australia and New Zealand: A Country-by-Country Guide (2026)

Last updated: 8 October 2026. Part of our region-by-region import guide series. Covers Japan, South Korea, Australia and...

Read Full Story
Comparator Sourcing for Clinical Trials: RLDs, Documents, Blinding and Supply Risk
Comparator Sourcing for Clinical Trials: RLDs, Documents, Blinding and Supply Risk

By the PharmaTradz BD Team. Published October 2026. Comparator sourcing is the buying of commercially marketed medicine...

Read Full Story
Early Access Program and Managed Access Program: Routes, Rules and Paperwork
Early Access Program and Managed Access Program: Routes, Rules and Paperwork

By the PharmaTradz BD Team. Published October 2026. An early access program is a legal route that lets a doctor treat a...

Read Full Story
Unlicensed Medicines in the UK: Specials, Imports and MHRA Rules Explained
Unlicensed Medicines in the UK: Specials, Imports and MHRA Rules Explained

By the PharmaTradz BD Team. Published October 2026. An unlicensed medicine in the UK is any medicinal product that does...

Read Full Story
NMPA Explained: China's Drug Regulator, Registration and Import Rules
NMPA Explained: China's Drug Regulator, Registration and Import Rules

By the PharmaTradz BD Team. Published October 2026. NMPA stands for the National Medical Products Administration, the n...

Read Full Story
BIOSECURE Act Explained: Status, Rules, Deadlines and What Pharma Buyers Should Do
BIOSECURE Act Explained: Status, Rules, Deadlines and What Pharma Buyers Should Do

By the PharmaTradz BD Team. Published October 2026. The BIOSECURE Act is a US law that stops federal agencies from buyi...

Read Full Story
API Manufacturers in China vs India: A Balanced Buyer's Comparison
API Manufacturers in China vs India: A Balanced Buyer's Comparison

By the PharmaTradz BD Team. Published October 2026. API manufacturers in China and India are two of the most important...

Read Full Story
Water for Injection vs Purified Water: Grades, Specifications and What Buyers Should Check
Water for Injection vs Purified Water: Grades, Specifications and What Buyers Should Check

By the PharmaTradz BD Team. Published October 2026. Water for injection (WFI) is the highest grade of bulk pharmaceutic...

Read Full Story
ICH Stability Guidelines: Storage Conditions, Climatic Zones and What Buyers Should Check
ICH Stability Guidelines: Storage Conditions, Climatic Zones and What Buyers Should Check

By the PharmaTradz BD Team. Published October 2026. The ICH stability guidelines are the internationally agreed rules f...

Read Full Story
Good Distribution Practice (GDP) in Pharma: EU, WHO and PIC/S Rules and What to Check
Good Distribution Practice (GDP) in Pharma: EU, WHO and PIC/S Rules and What to Check

By the PharmaTradz BD Team. Published October 2026. Good Distribution Practice (GDP) is the set of quality rules that k...

Read Full Story

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us